
About Refex Life Sciences Private Limited
Data last updated:
Refex Life Sciences Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Sherisha Technologies Private Limited. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 03 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U33112TN2021PTC141761. Its GSTIN is 33AAUCA8721D1ZN (Tamil Nadu).
The company has an authorised share capital of ₹500 Cr and a paid-up capital of ₹162.13 Cr. It is led by directors Dinesh Kumar Agarwal and Anil Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.86 Cr, a growth of 146% compared to the previous year. For the same year it recorded a net loss of ₹8.14 Cr (net margin -167.3%) and EBITDA of -₹4.95 Cr (EBITDA margin -101.7%). Revenue has grown at a compounded annual rate (CAGR) of 559% over three years.
As per MCA filings, the company has open charges of ₹460 Cr on record. Court records list 2 cases involving the company, including 2 filed against it. The company has 2 deals on record (1 convertible or debt financing, 1 secondary share transfer), with disclosed funding of ₹130 Cr; the latest was in November 2021.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website refex.co.in.
Company details
Contact details
Refex Life Sciences Private Limited's registered office is in Chennai, Tamil Nadu. Its website is refex.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSecond Floor Refex Towers Sterling Road Signal, 313 Valluvar Kottam High Road Nungambakkam, Chennai, Tamil Nadu, India – 600034
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Refex Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Refex Life Sciences Private Limited
FY 2025 filings availableRefex Life Sciences Private Limited reported revenue of ₹4.86 Cr (up 146% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 559% over three years, including 146% growth in the latest year. EBITDA fell 390% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.95 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.14 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -101.7% | ||||
| Net Profit Margin | -167.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Refex Life Sciences Private Limited, buy the company report.
Board of directors of Refex Life Sciences Private Limited
Refex Life Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dinesh Kumar Agarwal | Director | 03 Mar 2021 | 5 Years 8 Months | Current |
| Anil Jain | Additional Director | 11 Nov 2025 | 1 Years 0 Months | Current |
Auditor
Refex Life Sciences Private Limited is audited by ABCD & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABCD & Co | FY 2023 | 016415S |
Shareholding
The shareholding of Refex Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Refex Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jul 2025 | 101161332 | Others | ₹335 Cr | Open | |
| 17 May 2023 | 100720123 | Others | ₹125 Cr | Open |
To see the full charge records of Refex Life Sciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Refex Life Sciences Private Limited has 2 deals on record (1 convertible or debt financing, 1 secondary share transfer), with disclosed funding of ₹130 Cr; the latest was in November 2021.
Deals on record (1 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2021 | Secondary share transfer | Undisclosed | Buyer: Sherisha Technologies Private Limited Seller: an individual |
To see the full deal history of Refex Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Refex Life Sciences Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Commercial suit | Filed against the company by Mape Pharmascience LLP and Anr and 1 other | Disposed |
| High Court, TAMIL NADU | Arbitration matter | Filed against the company by an individual | Disposed |
To see the full case history of Refex Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Refex Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Refex Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAUCA8721D1ZN | Tamil Nadu | Active | 15 Mar 2023 |
To see the full GST registrations and return filing status of Refex Life Sciences Private Limited, buy the company report.
Recent activity
Refex Life Sciences Private Limited has 8 board changes on record since 2021: 5 appointments and 3 cessations. The latest: Anil Jain was appointed as Additional Director on 11 Nov 2025.
3 earlier events are in the company report.
News
Frequently asked questions
Refex Life Sciences is an active private limited company based in Chennai, Tamil Nadu, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 03 March 2021 (5+ years old) and is registered under CIN U33112TN2021PTC141761.
Refex Life Sciences has 2 current directors:
- Dinesh Kumar Agarwal - Director
- Anil Jain - Additional Director
The latest financial statements of Refex Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Refex Life Sciences is 33AAUCA8721D1ZN, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Refex Life Sciences is U33112TN2021PTC141761. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Refex Life Sciences has 2 court cases on record: 2 filed against it.
Refex Life Sciences was incorporated on 03 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
Refex Life Sciences has 2 deals on record (1 convertible or debt financing, 1 secondary share transfer), with disclosed funding of ₹130 Cr; the latest was in November 2021.
Anil Jain was appointed as Additional Director on 11 Nov 2025. Patrik Vijay Kumar Francis Arun Kumar ceased to be Director on 11 Nov 2025. Puthuseri Veedu Pasupathy ceased to be Whole-Time Director on 01 Apr 2025. Refex Life Sciences has 8 board changes on record in total.
Refex Life Sciences can be reached through the website refex.co.in. Its registered office is in Chennai, Tamil Nadu, India.

